Patent Service Landscape for Healthcare Startups

The US-India Advantage: Strategic Work Distribution

Our patenting service model strategically distributes patent work between US and Indian professionals to optimize both quality and cost-effectiveness.

US-based registered patent attorneys and agents maintain direct client relationships and provide strategic oversight, while our Indian team contributes technical expertise and support services that enhance the overall patent prosecution process.

The US patenting team provides:

• Direct client communication and strategic guidance

• Final review and quality assurance of all submissions

• USPTO communications management

• Strategic decision-making and recommendations

• Direct representation before the USPTO

The Indian patenting team contributes:

• Technical research and analysis

• Prior art searching and analysis

• Draft amendment of patent application

• Office action response support

• Patent drawings and illustrations

• Technical specifications development

Why Us
Cost-Effective Service Delivery & Optimized Resource Allocation

Our working model achieves cost savings through:

• Strategic distribution of technical tasks

• Efficient workflow management

• Time zone advantages for faster turnaround

• Reduced overhead costs

• Economies of scale

Transparent Pricing Structure

We offer clear pricing models that reflect our cost advantages:

• Fixed-fee arrangements for standard services

• Customized packages for portfolio clients

• Volume-based discounting

• Flexible engagement models

At the intersection of digital health, artificial intelligence, and neurophysiological monitoring, the technology behind it has catalyzed an unprecedented wave of innovation in wellness and health diagnostics. For startups and established medical device companies alike, understanding the freedom to operate system is crucial for protecting intellectual property in this sensitive and high-growth domain.

For example, A61B5/165—Evaluating the state of mind, e.g. depression, anxiety serves as the primary gateway for patent protection in this space.

Understanding Hierarchy: From Broad Medical Diagnostics to Specific Ailment States

Foundation: A61B5/00 (Measuring for Diagnostic Purposes)

At the apex of this taxonomy sits A61B5/00, encompassing all technologies designed for measuring physiological parameters for diagnostic purposes. This classification represents the foundation of modern medical diagnosis, covering everything from blood pressure monitors to advanced neuro-imaging systems. For mental health applications, it provides the structural framework that supports more specialized subclasses, establishing the fundamental requirement that inventions must produce measurable, objective data that correlates with clinical conditions.

Psychological Assessment Branch: A61B5/16

Drilling down, A61B5/16—Devices for psychotechnics; Testing reaction times; Devices for evaluating the psychological state represents the first major specialization toward mental health. This category captures traditional psychometric tools and reaction-time assessments, but has evolved dramatically to include digital platforms that gamify cognitive testing, smartphone apps that measure tap-rhythm variability as an anxiety indicator, and VR-based social interaction simulators that gauge stress responses. It's a broad church that welcomes both centuries-old psychological testing methodologies and cutting-edge digital phenotyping approaches.

In recent years, A61B5/165 itself has become one of the most dynamic and commercially significant classifications in digital health. It explicitly covers technologies that evaluate mental states, with particular emphasis on depression and anxiety—the two most prevalent mental health disorders globally.

Patent applications in this subclass reveal fascinating innovation patterns:

• Voice biomarker analysis: Systems that analyze microtremors, pitch variability, and speech pause patterns to detect depressive episodes

• Digital behavior monitoring: Passive smartphone sensors tracking sleep disruption, social withdrawal, and activity reduction as depression indicators

• Eye-tracking correlates: Pupillometry and gaze-fixation patterns that correlate with anxiety levels

• Thermal imaging: Facial temperature mapping to identify stress-induced vasoconstriction patterns

The classification specifically accommodates both active assessment (directed tests) and passive monitoring (continuous background evaluation), reflecting the shift from episodic clinical screening to 24/7 digital phenotyping.

Prior Art Challenges to Determine Novelty Aspect 

The field suffers from conceptually overlapping prior art. Patent attorneys and Patent Agents must carefully distinguish new applications from existing psychometric tests, fitness wearables, and general-purpose AI. The key lies in specific physiological-psychological correlations and validated clinical endpoints rather than generic "wellness" monitoring.

Patent Landscape of Health Related Diagnostics: Navigating Technology based Solutions for Depression and Anxiety Assessment